From: Persistence of TEL-AML1 fusion gene as minimal residual disease has no additive prognostic value in CD 10 positive B-acute lymphoblastic leukemia: a FISH study
Clinical course
CR1
CR2
CR2, CNS relapse and death
Resistant and death
Total
P
T (12; 21) at Diagnosis
Yes
20
9
1
0
30
0.003
No
31
2
8
50
29
40
3
80